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Type 2 diabetes is characterized by frequent ectopic fat accumulation in several tissues and organs. In particular, a number of studies
showed that these subjects frequently have hepatic fat accumulation, which may play a role in the metabolic abnormalities typical
of diabetes and has been also linked to increased risk for cardiovascular disease. In the last decade, the effect of exercise on ectopic
fat content of type 2 diabetic patients has raised growing interest. However, there are only a few small randomized controlled trials
on this topic. Results from these intervention studies indicate that exercise training, independent of dietary modifications, may
reduce hepatic fat content and serum transaminases in these patients, suggesting that exercise per se may be an effective strategy
to be combined with the traditional dietary interventions. As regards the different training modalities, there is recent evidence that
both aerobic and resistance exercise may equally reduce hepatic fat accumulation in type 2 diabetic subjects. However, information
regarding the effect of exercise on liver histology and fat accumulation in other ectopic sites is still very limited.
1. Introduction
Type 2 diabetes is characterized by frequent ectopic fat
accumulation in several tissues and organs (liver, skeletal
muscle, heart, and pancreas) and unfavorable adipose tissue
distribution [1]. Ectopic fat accumulation is defined by the
deposition of triglycerides within cells of nonadipose tissues,
which normally contain only small amounts of fat. Over
the past decade, magnetic resonance (MR) spectroscopy has
been used as the gold standard technique for noninvasive
quantification of intramyocellular, hepatic, andmore recently
myocardial and pancreatic lipids. However, ectopic fat con-
tent can also be assessed by other methods, such as computed
tomography andmagnetic resonance imaging, which provide
data on hepatic fat content that correlate very well with those
obtained by the proton MR spectroscopy as well as with the
histopathologic findings [2].
In particular, a number of studies have shown that
subjects with type 2 diabetes frequently suffer from nonal-
coholic fatty liver disease (NAFLD), a term which includes
a variety of pathological conditions, from simple steatosis
to nonalcoholic steatohepatitis and cirrhosis. Available data
suggest that approximately 50% to 70% of patients with type
2 diabetes have NAFLD, whereas the frequency of ectopic fat
infiltration in other tissues has yet to be fully investigated.
Interestingly, this phenomenon seems to have prominent
clinical implications. In particular, there is evidence that
NAFLD may play a role in the progression of insulin resis-
tance and in several other metabolic abnormalities typical of
diabetes, as well as in the increased risk for cardiovascular
disease of these subjects [3].
The mechanisms underlying the relationships between
type 2 diabetes and ectopic fat accumulation in the body
are still largely unclear, and the specific approach to this
phenomenon has yet to be determined. However, it is widely
accepted that lifestyle changes, that is, diet and exercise, are
the mainstay of treatment, as they may improve metabolic
control and reduce body fat in these patients. Conversely, lim-
ited information is available on the effects of pharmacological
treatments on ectopic fat infiltration.
In this paper we review the literature regarding the role
of exercise on ectopic fat accumulation in subjects with type
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2 diabetes. It should be noted that most studies on this issue
specifically analyzed NAFLD.
2. Strategies in the Treatment of Ectopic
Fat Accumulation
According to the present knowledge about pathophysiology
of ectopic fat accumulation, there are several potential targets
for this phenomenon [4]. Weight loss in overweight/obese
patients is an obvious target and the widely accepted mile-
stone of treatment. In a recent meta-analysis or randomized
trials, it was observed that a weight loss of at least 7% is
effective in improving histological disease activity, although it
was achieved by less than 50% of patients [5]. Additional pro-
posed strategies include targeting insulin resistance, hyper-
glycemia, dyslipidemia, oxidative stress, and inflammation.
Research focusing on specific dietary components suggests
that both macronutrients and micronutrients may play a role
in the development of NAFLD [6]. From this point of view,
there is evidence of adverse effects of fructose and favourable
effects of polyunsaturated fatty acids (PUFA), possibly linked
to opposite effects of these nutrients on inflammation. The
role of vitamins and minerals in this field is also under inves-
tigation. Interestingly, lifestyle improvement may favourably
affect all these potential mechanisms underlying ectopic fat
accumulation.
Among the pharmacological options, statins showed
some efficacy in the treatment of NAFLD [5]. As regards
antidiabetic medications, insulin sensitizers and glucagon-
like peptide-1 (GLP-1) analogs appear to be the most inter-
esting options. However, the literature on this topic is still
limited. Several studies assessed the potential efficacy on
NAFLD of the insulin sensitizer metformin, which is the
first-line medication in the treatment of type 2 diabetes and
primarily improves hepatic insulin sensitivity. These studies
consistently showed that metforminmay reduce serum levels
of liver enzymes, a surrogate marker of NAFLD. However,
most of these studies were uncontrolled and liver histology
results were inconsistent [4, 5].
The effect on NAFLD of thiazolidinediones, another
class of insulin sensitizers, which are agonists of peroxisome
proliferator activated gamma (PPAR-gamma) receptor, was
also investigated by several studies. These drugs improve
insulin action primarily at the skeletal muscle level. However,
PPAR-gamma receptor is highly expressed in adipose tissue.
Moreover, these medications induce a redistribution of body
fat depots, making these molecules of particular interest
for targeting ectopic fat accumulation. Available data from
a few randomized trials support this hypothesis, showing
that thiazolidinediones may improve liver histology [5]. In
particular, these drugs consistently reduced hepatic steatosis
and inflammation; in addition, in patients with stable stage
fibrosis, they significantly reduced progression of fibrosis
[5]. Nonetheless, large RCTs are needed before we can
consider thiazolidinediones a specific treatment for ectopic
fat accumulation.
As regards GLP-1 analogs, which belong to the incretin
class and favour weight loss, there are some ongoing random-
ized trials. Preliminary data have shown the reduction of liver
enzyme levels and hepatic steatosis after treatment with these
drugs, suggesting they could be potentially useful in targeting
NAFLD in diabetic patients.
3. The Role of Exercise Training in
Type 2 Diabetes
Although increased physical activity has for decades been
considered a first-line issue in the treatment of type 2
diabetes, the role of exercise training in these subjects
has recently raised renewed and considerable interest in
both clinical and scientific terms. In this regard, a recent
joint position statement of the American College of Sport
Medicine and the American Diabetes Association suggested
that, whenever possible, both aerobic and resistance exercise
training for subjects with type 2 diabetes, should be used
to improve glycemic control, cardiovascular risk factors,
and body composition [7]. Aerobic and resistance exercise
training share some general effects but differ in their specific
characteristics. Aerobic training, such as walking or cycling,
involves repetitive and rhythmic contraction of large mus-
cle groups, promoting cardiorespiratory fitness. Conversely,
resistance training, such as weightlifting, typically engages
relatively slow, high force contractions, promoting muscu-
loskeletal fitness and stimulating the increase in muscle
proteins and muscle cross-sectional area.
In patients with type 2 diabetes, some recent head-to-
head RCTs have shown that both aerobic and resistance
training may elicit similar results in terms of a number of
endpoints, such as glucose control, insulin sensitivity, and
body composition [8–10]. Although the results of some of
these studies suggested that combination training could be
more effective in these subjects than aerobic or resistance
training alone [9, 10], it should be pointed out that in these
trials exercise volume was higher in the combination groups,
precluding a definitive answer to this crucial question.
As regards ectopic fat, regular physical activity may
reduce its content through several different mechanisms,
including increased hepatic and muscle fatty acid oxidation,
reduced postprandial hepatic lipogenesis, and reduced fatty
acid and proinflammatory molecule flow to the liver and
other organs. However, to date only a few intervention
studies have assessed the effect of exercise, either alone or
in combination with diet, on ectopic (especially hepatic) fat
content [11–16] (Table 1). Moreover, most of these studies
included a combination of exercise and caloric restriction,
making it difficult to assess the role of exercise per se.
4. Effect of Exercise Training on Liver Fat
Content in Type 2 Diabetes
Aerobic exercise is usually recommended in themanagement
of NAFLD. However, not all subjects are able to perform this
type of exercise. Moreover, until now only one randomized
controlled trial has assessed the effect of exercise alone on
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hepatic fat content in subjects with type 2 diabetes [16],
while four RCTs have compared the effect of combined
interventions with both aerobic exercise and hypocaloric diet
versus diet alone or standard diabetes support and education
programs [11, 13–15].
We have recently randomized 31 type 2 diabetic patients
with NAFLD to regular training with either aerobic or
resistance exercise. Interestingly, after 4 months hepatic fat
content was markedly reduced, to a similar extent, in both
groups, showing that these exercise modalities are equally
effective in type 2 diabetic patients with NAFLD [16]. It
is noteworthy that hepatic steatosis disappeared in about
25% of these diabetic subjects. This reduction in hepatic
fat accumulation was accompanied by concurrent, mild but
significant improvements in both anthropometric [BMI, total
and truncal body fat, abdominal visceral (VAT), and subcu-
taneous (SAT) adipose tissue] andmetabolic features (insulin
sensitivity, HbA1c, triglycerides).These results were indepen-
dent of the effect of diet, as participants were instructed to
maintain their baseline calorie intake by consuming healthy
self-selected foods, and compliance to dietary recommen-
dations was confirmed by a stable body weight in the pre-
intervention period and the results of the food recall at the
end of intervention.
Conversely, Bonekamp et al. in a sample of 45 subjects
with type 2 diabetes have assessed the effect of combined,
moderate intensity training with both aerobic and resistance
exercise, without any associated caloric restriction [12].Their
preliminary results suggested that combined exercise training
may reduce hepatic fat content, independently of any changes
in body composition and metabolic features.
In agreement with these findings, a one-month aerobic
training intervention, carried out in a sample of 19 non-
diabetic obese individuals, reported a 21% reduction of
hepatic fat content, in the absence of any significant body
weight reduction [17]. Similarly, Hallsworth et al. [18] have
recently reported that in 18 subjects with NAFLD, some
of them with type 2 diabetes, there was a 13% reduction
of hepatic fat content after 8 weeks of resistance exercise,
without any changes in body weight.
Other studies reported that, in the short term, hepatic fat
content is similarly reduced after diet only or exercise plus
diet interventions [11, 13–15]. Tamura et al. [11], in 14 type
2 diabetic patients, showed a similar decrease of hepatic fat
content, with a reduction of bodymass index, after two weeks
of diet only (60% carbohydrate, 25% fat, 15% protein, and
mean total energy intake of 27.9 kcal/kg ideal body weight)
or diet plus exercise (30minutes ofmoderate intensity aerobic
exercise, 5-6 times aweek).More recently, in 45 obese subjects
with type 2 diabetes, Bozzetto et al. [15] compared the effect
of high-carbohydrate/high fiber/low glycemic index diet or
multi-unsaturated fatty acid (MUFA) diet, with or without
a concurrent moderate intensity aerobic exercise program
of 45 minutes 2 times a week. After 8 weeks, the authors
reported that MUFA intervention, as compared with the
control diet, was associated with a significant and clinically
relevant reduction of hepatic fat content, without reduction
in body weight. These findings were independent of the
associated training program, as the reduction of liver fat
content was similar in both the MUFA diet alone and the
MUFA diet plus exercise protocols. Nonetheless, it could be
hypothesized that the duration of the interventions was too
short to detect differences in changes of hepatic fat content
between the exercise plus diet group and the diet only group.
Even more important, these authors reported a negligible
improvement of only 1mL/kg/min of peak oxygen uptake in
the MUFA plus exercise group compared with the MUFA
only group. Thus, it can be speculated that training volume
and/or intensity were not sufficiently adequate to improve
cardiorespiratory fitness of these subjects.
Two studies [13, 14] carried out in the cohort of the Look
AHEAD Study—a multicenter prospective study comparing
intensive lifestyle intervention, including caloric restriction
and at least 175min of moderate aerobic physical activity per
week, versus standard care in diabetic subjects—reported that
after 1 year of intervention there was a significant decrease
in hepatic fat content and a reduced incidence of NAFLD
in patients randomized to the intensive lifestyle group. In
particular, themedian percent decrease in steatosis was 50.8%
in the intervention lifestyle group versus 22.8% in the control
group [13]. In addition, 3% of participants in the intervention
group versus 26% of those in the control group, who were
without NAFLD at baseline, developed NAFLD during the
study. Interestingly, similar changes in hepatic fat content
were found in both men and women [14].
Overall, these data support the recommendation for
weight loss using lifestyle changes as the first step in
patients with NAFLD, including those with type 2 diabetes.
In addition, they suggest that either aerobic or resistance
exercise per se is effective in reducing hepatic fat content.
Unfortunately, due to the limited information available, it
remains unclear what amount/volume and what intensity of
exercise is optimal in targeting a reduction of hepatic fat
content.
5. Summary
In the last decade, the effect of exercise on ectopic, especially
hepatic, fat content of type 2 diabetic patients has raised
growing interest. However, there are still only a few small
RCTs on this topic. Results from these intervention stud-
ies are promising, as they indicate that exercise training,
independent of dietary modifications, can reduce hepatic fat
content in these patients, suggesting that exercise per se may
be an effective strategy to be combined with the traditional
low calorie diet interventions.
The extent of improvement induced by exercise training
in hepatic fat content appears to be quite different in these
studies. These differences might be explained by differences
in exercise volume and intensity, as well as in the duration
of the interventions, although they can also be linked to the
different techniques used for the measurement of fat content.
Future research should further address the effects of both
aerobic and resistance exercise, alone or in combination, on
ectopic fat accumulation of these subjects, by focusing on the
differences between training protocols in terms of exercise
frequency, duration, and intensity, in order to establish which
International Journal of Endocrinology 5
training model is more effective in reducing ectopic fat
accumulation and thereby counteracting themultiple adverse
effects of this phenomenon.
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